Professional Documents
Culture Documents
CF Host Dept List 2023 24 v10 1
CF Host Dept List 2023 24 v10 1
The Department hosts 1) the Regional Reference Center for Parkinson’s disease and related disorders (CEP), 2) the French
The Department hosts 1) the Regional Reference Center for Parkinson’s disease and related disorders (CEP), 2) the French
yes
yes
yes
yes
yes
_
_
_
N/A
N/A
N/A
N/A
Certification of Department: French Ministry of Health and European Commission (Coordinator oft he European Reference
Certification of Department: French Ministry of Health and European Commission (Coordinator oft he European Reference
Certification of Department: French Ministry of Health and European Commission (Coordinator oft he European Reference
Certification of Department: French Ministry of Health and European Commission (Coordinator oft he European Reference
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
HCERES, Francce
HCERES, Francce
HCERES, Francce
HCERES, Francce
1) Reference Center for Rare Disease (Dystonia and movement disorder) accreditation by the French governement and Eu
1) Reference Center for Rare Disease (Dystonia and movement disorder) accreditation by the French governement and Eu
1) Reference Center for Rare Disease (Dystonia and movement disorder) accreditation by the French governement and Eu
1) Reference Center for Rare Disease (Dystonia and movement disorder) accreditation by the French governement and Eu
1) Reference Center for Rare Disease (Dystonia and movement disorder) accreditation by the French governement and Eu
_
_
_
_
_
_
DGfE
DGfE
_
_
_
_
_
_
_
_
_
_
_
_
_
_
rch labs for experimental neurovascular research, clinical neurovascular research, neuroimmunology and movement disorders and ima
rch labs for experimental neurovascular research, clinical neurovascular research, neuroimmunology and movement disorders and ima
rch labs for experimental neurovascular research, clinical neurovascular research, neuroimmunology and movement disorders and ima
rch labs for experimental neurovascular research, clinical neurovascular research, neuroimmunology and movement disorders and ima
rch labs for experimental neurovascular research, clinical neurovascular research, neuroimmunology and movement disorders and ima
rch labs for experimental neurovascular research, clinical neurovascular research, neuroimmunology and movement disorders and ima
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
Yes. Certified epilepsy center (German chapter of ILAE) and certified neuromuscular center (national).
Yes. Certified epilepsy center (German chapter of ILAE) and certified neuromuscular center (national).
Yes. Certified epilepsy center (German chapter of ILAE) and certified neuromuscular center (national).
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
Swiss Cert 030-02-152-00019
Swiss Cert 030-02-152-00020
Swiss Cert 030-02-152-00021
_
_
_
_
_
846035
_
_
ESO Stroke Unit certification / ERN RND accreditation
ESO Stroke Unit certification / ERN RND accreditation
ESO Stroke Unit certification / ERN RND accreditation
ESO Stroke Unit certification / ERN RND accreditation
ESO Stroke Unit certification / ERN RND accreditation
ESO Stroke Unit certification / ERN RND accreditation
ESO Stroke Unit certification / ERN RND accreditation
ESO Stroke Unit certification / ERN RND accreditation
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
RAPY FOR PARKINSON DISEASE AND DYSTONIA (DBS, APOMORFINE-PUMP, LCIG) b) EXPERTISE IN BOTULINUM TOXIN INJECTION TR
RAPY FOR PARKINSON DISEASE AND DYSTONIA (DBS, APOMORFINE-PUMP, LCIG) b) EXPERTISE IN BOTULINUM TOXIN INJECTION TR
RAPY FOR PARKINSON DISEASE AND DYSTONIA (DBS, APOMORFINE-PUMP, LCIG) b) EXPERTISE IN BOTULINUM TOXIN INJECTION TR
RAPY FOR PARKINSON DISEASE AND DYSTONIA (DBS, APOMORFINE-PUMP, LCIG) b) EXPERTISE IN BOTULINUM TOXIN INJECTION TR
_
_
_
_
_
_
Regione Emilia-Romagna
Regione Emilia-Romagna
Regione Emilia-Romagna
Regione Emilia-Romagna
Regione Emilia-Romagna
Regione Emilia-Romagna
morphine, and levodopa-carbidopa intestinal gel in Parkinson’s disease; botulinum toxin and advanced headache treatments; advanced
morphine, and levodopa-carbidopa intestinal gel in Parkinson’s disease; botulinum toxin and advanced headache treatments; advanced
morphine, and levodopa-carbidopa intestinal gel in Parkinson’s disease; botulinum toxin and advanced headache treatments; advanced
morphine, and levodopa-carbidopa intestinal gel in Parkinson’s disease; botulinum toxin and advanced headache treatments; advanced
morphine, and levodopa-carbidopa intestinal gel in Parkinson’s disease; botulinum toxin and advanced headache treatments; advanced
_
_
_
_
_
_
_
_
Hospital – SSN (National Health Service)
Hospital – SSN (National Health Service)
Hospital – SSN (National Health Service)
Hospital – SSN (National Health Service)
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
EAN and ESNCH European Reference Neurosonology Center
Ministry of Health of the Republic of Serbia; The Agency for accreditation of health care institutions of Serbia
Ministry of Health of the Republic of Serbia; The Agency for accreditation of health care institutions of Serbia
Ministry of Health of the Republic of Serbia; The Agency for accreditation of health care institutions of Serbia
Ministry of Health of the Republic of Serbia; The Agency for accreditation of health care institutions of Serbia
Ministry of Health of the Republic of Serbia; The Agency for accreditation of health care institutions of Serbia
Ministry of Health of the Republic of Serbia; The Agency for accreditation of health care institutions of Serbia
Ministry of Health of the Republic of Serbia; The Agency for accreditation of health care institutions of Serbia
Ministry of Health of the Republic of Serbia; The Agency for accreditation of health care institutions of Serbia
Ministry of Health of the Republic of Serbia; The Agency for accreditation of health care institutions of Serbia
Ministry of Health of the Republic of Serbia; The Agency for accreditation of health care institutions of Serbia
Ministry of Health of the Republic of Serbia; The Agency for accreditation of health care institutions of Serbia
Ministry of Health of the Republic of Serbia; The Agency for accreditation of health care institutions of Serbia
Ministry of Health of the Republic of Serbia; The Agency for accreditation of health care institutions of Serbia
Ministry of Health of the Republic of Serbia; The Agency for accreditation of health care institutions of Serbia
Ministry of Health of the Republic of Serbia; The Agency for accreditation of health care institutions of Serbia
ISO 9001:2015, AACI
ISO 9001:2015, AACI
ISO 9001:2015, AACI
ISO 9001:2015, AACI
ISO 9001:2015, AACI
ISO 9001:2015, AACI
ISO 9001:2015, AACI
ISO 9001:2015, AACI
ISO 9001:2015, AACI
ISO 9001:2015, AACI
ISO 9001:2015, AACI
_
Stroke center, MS center; Referenzzentrum für neuromuskuläre Krankheiten
Stroke center, MS center; Referenzzentrum für neuromuskuläre Krankheiten
Stroke center, MS center; Referenzzentrum für neuromuskuläre Krankheiten
Stroke center, MS center; Referenzzentrum für neuromuskuläre Krankheiten
Stroke center, MS center; Referenzzentrum für neuromuskuläre Krankheiten
Stroke center, MS center; Referenzzentrum für neuromuskuläre Krankheiten
www.siwf-register.ch (categroy A)
www.siwf-register.ch (categroy A)
www.siwf-register.ch (categroy A)
www.siwf-register.ch (categroy A)
www.siwf-register.ch (categroy A)
www.siwf-register.ch (categroy A)
www.siwf-register.ch (categroy A)
_
_
_
_
_
by national body
by national body
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
Dept of clinical neurology, NHNN and UCLH
Dept of clinical neurology, NHNN and UCLH
Dept of clinical neurology, NHNN and UCLH
Dept of clinical neurology, NHNN and UCLH
Dept of clinical neurology, NHNN and UCLH
Dept of clinical neurology, NHNN and UCLH
Dept of clinical neurology, NHNN and UCLH
Dept of clinical neurology, NHNN and UCLH
Dept of clinical neurology, NHNN and UCLH
Dept of clinical neurology, NHNN and UCLH
participate in and gain exposure to clinical and research activities in the department. We work closely with the neuro-opht
_
_
We are one of 14 Parkinson´s Foundation-accredited International Centres of Excellence in Europe, an accredited UK Parki
We are one of 14 Parkinson´s Foundation-accredited International Centres of Excellence in Europe, an accredited UK Parki
Tertiary and Quaternary Neurosciences Centre (NHS England)
Tertiary and Quaternary Neurosciences Centre (NHS England)
Tertiary and Quaternary Neurosciences Centre (NHS England)
Tertiary and Quaternary Neurosciences Centre (NHS England)
Tertiary and Quaternary Neurosciences Centre (NHS England)
Tertiary and Quaternary Neurosciences Centre (NHS England)
Tertiary and Quaternary Neurosciences Centre (NHS England)
Tertiary and Quaternary Neurosciences Centre (NHS England)
Tertiary and Quaternary Neurosciences Centre (NHS England)
Tertiary and Quaternary Neurosciences Centre (NHS England)
Tertiary and Quaternary Neurosciences Centre (NHS England)
Tertiary and Quaternary Neurosciences Centre (NHS England)
Tertiary and Quaternary Neurosciences Centre (NHS England)
Tertiary and Quaternary Neurosciences Centre (NHS England)
Tertiary and Quaternary Neurosciences Centre (NHS England)
Tertiary and Quaternary Neurosciences Centre (NHS England)
Tertiary and Quaternary Neurosciences Centre (NHS England)
Tertiary and Quaternary Neurosciences Centre (NHS England)
Tertiary and Quaternary Neurosciences Centre (NHS England)
Tertiary and Quaternary Neurosciences Centre (NHS England)
Tertiary and Quaternary Neurosciences Centre (NHS England)
Tertiary and Quaternary Neurosciences Centre (NHS England)
Tertiary and Quaternary Neurosciences Centre (NHS England)
Tertiary and Quaternary Neurosciences Centre (NHS England)
Tertiary and Quaternary Neurosciences Centre (NHS England)
_
_
ning accreditation
ning accreditation
ning accreditation
ning accreditation
ning accreditation
ning accreditation
ning accreditation
ning accreditation
ning accreditation
ning accreditation
ning accreditation
ning accreditation
ning accreditation
ning accreditation
ning accreditation
ated disorders (CEP), 2) the French Reference Centre for MSA, and 3) the Certified regional reference Centre for Dementia and related
ated disorders (CEP), 2) the French Reference Centre for MSA, and 3) the Certified regional reference Centre for Dementia and related
dinator oft he European Reference Network for Rare and Complex Epilepsies, ERN EpiCARE)
dinator oft he European Reference Network for Rare and Complex Epilepsies, ERN EpiCARE)
dinator oft he European Reference Network for Rare and Complex Epilepsies, ERN EpiCARE)
dinator oft he European Reference Network for Rare and Complex Epilepsies, ERN EpiCARE)
y the French governement and European Acreditation (ERN), and support of Dystonia Europe (patients advocay group), 2) Reference
y the French governement and European Acreditation (ERN), and support of Dystonia Europe (patients advocay group), 2) Reference
y the French governement and European Acreditation (ERN), and support of Dystonia Europe (patients advocay group), 2) Reference
y the French governement and European Acreditation (ERN), and support of Dystonia Europe (patients advocay group), 2) Reference
y the French governement and European Acreditation (ERN), and support of Dystonia Europe (patients advocay group), 2) Reference
y and movement disorders and imaging in peripheral neurology
y and movement disorders and imaging in peripheral neurology
y and movement disorders and imaging in peripheral neurology
y and movement disorders and imaging in peripheral neurology
y and movement disorders and imaging in peripheral neurology
y and movement disorders and imaging in peripheral neurology
ter (national).
ter (national).
ter (national).
N BOTULINUM TOXIN INJECTION TREATMENT
N BOTULINUM TOXIN INJECTION TREATMENT
N BOTULINUM TOXIN INJECTION TREATMENT
N BOTULINUM TOXIN INJECTION TREATMENT
ed headache treatments; advanced MRI and neural systems computational modelling; antisense oligonucleotide therapy in ALS
ed headache treatments; advanced MRI and neural systems computational modelling; antisense oligonucleotide therapy in ALS
ed headache treatments; advanced MRI and neural systems computational modelling; antisense oligonucleotide therapy in ALS
ed headache treatments; advanced MRI and neural systems computational modelling; antisense oligonucleotide therapy in ALS
ed headache treatments; advanced MRI and neural systems computational modelling; antisense oligonucleotide therapy in ALS
institutions of Serbia
institutions of Serbia
institutions of Serbia
institutions of Serbia
institutions of Serbia
institutions of Serbia
institutions of Serbia
institutions of Serbia
institutions of Serbia
institutions of Serbia
institutions of Serbia
institutions of Serbia
institutions of Serbia
institutions of Serbia
institutions of Serbia
ork closely with the neuro-ophthalmology, movement disorders, and cognitive disorders teams.
e in Europe, an accredited UK Parkinson´s Excellence Network Centre and one of the few centres in the UK able to provide invasive the
e in Europe, an accredited UK Parkinson´s Excellence Network Centre and one of the few centres in the UK able to provide invasive the
e Centre for Dementia and related disorders (CMRR). All are certified by the French Health Ministry. The Department is also recognized
e Centre for Dementia and related disorders (CMRR). All are certified by the French Health Ministry. The Department is also recognized
ents advocay group), 2) Reference Center for Rare Disease (Tourette syndrome) accreditation by the French governement, 3) Expert ce
ents advocay group), 2) Reference Center for Rare Disease (Tourette syndrome) accreditation by the French governement, 3) Expert ce
ents advocay group), 2) Reference Center for Rare Disease (Tourette syndrome) accreditation by the French governement, 3) Expert ce
ents advocay group), 2) Reference Center for Rare Disease (Tourette syndrome) accreditation by the French governement, 3) Expert ce
ents advocay group), 2) Reference Center for Rare Disease (Tourette syndrome) accreditation by the French governement, 3) Expert ce
gonucleotide therapy in ALS
gonucleotide therapy in ALS
gonucleotide therapy in ALS
gonucleotide therapy in ALS
gonucleotide therapy in ALS
he UK able to provide invasive therapies for advance Parkinson´s disease such as intrajejunal levodopa infusion, apomorphine infusion
he UK able to provide invasive therapies for advance Parkinson´s disease such as intrajejunal levodopa infusion, apomorphine infusion
The Department is also recognized as Movement Disorder expert center by the International Parkinson and Movement Disorders Soci
The Department is also recognized as Movement Disorder expert center by the International Parkinson and Movement Disorders Soci
French governement, 3) Expert centre for Parkinson disease accreditation by the French governement and Michael J Fox association
French governement, 3) Expert centre for Parkinson disease accreditation by the French governement and Michael J Fox association
French governement, 3) Expert centre for Parkinson disease accreditation by the French governement and Michael J Fox association
French governement, 3) Expert centre for Parkinson disease accreditation by the French governement and Michael J Fox association
French governement, 3) Expert centre for Parkinson disease accreditation by the French governement and Michael J Fox association
opa infusion, apomorphine infusion an deep brain stimulation (DBS) as well as being the global lead for delivering holistic wellness orie
opa infusion, apomorphine infusion an deep brain stimulation (DBS) as well as being the global lead for delivering holistic wellness orie
son and Movement Disorders Society (MDS) and the French Reference Centre for MSA is member of the ERN-RND.
son and Movement Disorders Society (MDS) and the French Reference Centre for MSA is member of the ERN-RND.
ent and Michael J Fox association
ent and Michael J Fox association
ent and Michael J Fox association
ent and Michael J Fox association
ent and Michael J Fox association
for delivering holistic wellness orientated non-motor treatment packages for Parkinson´s.
for delivering holistic wellness orientated non-motor treatment packages for Parkinson´s.
f the ERN-RND.
f the ERN-RND.
topic